1-3 of 3
Philip Reigan
Close
Sort by
Journal Articles

The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation

Maria L. Amaya, Anagha Inguva, Shanshan Pei, Courtney Jones, Anna Krug, Haobin Ye, Mohammad Minhajuddin, Amanda Winters, Steffanie L. Furtek, Fabia Gamboni, Brett Stevens, Angelo D’Alessandro, Daniel A. Pollyea, Philip Reigan, Craig T. Jordan
Journal: Blood
Blood (2022) 139 (4): 584–596.
https://doi.org/10.1182/blood.2021013201
Published: 2022
Includes: Supplemental data
Journal Articles

ALDH Genes and Reactive Aldehydes Play Important Roles in HSCs and Leukemia and May Be Exploited to Treat AML

Maura Gasparetto, MD, Craig T. Jordan, PhD, Mohammad Minhajuddin, Daniel A Pollyea, MD, MS, Vasilis Vasilou, Philip Reigan, PhD, R. Keith Humphries, MD, PhD, Clayton A. Smith, MD, FRCPC
Journal: Blood
Blood (2013) 122 (21): 2893.
https://doi.org/10.1182/blood.V122.21.2893.2893
Published: 2013
Journal Articles

A Novel Missense Mutation in FGG (c.944C>A) Encodes for An Amino Acid Change (p.Ala315Asp) in the Gamma Chain of Fibrinogen Causing Hypofibrinogenemia and a Thrombotic Phenotype

Larissa Bornikova, MD, Gary Brodsky, PhD, Keith B Neeves, PhD, Rita Marchi, PhD, Donald S Backos, PhD, Philip Reigan, PhD, Alisa S. Wolberg, PhD, Marilyn J. Manco-Johnson, MD, Jorge A Di Paola, MD
Journal: Blood
Blood (2011) 118 (21): 856.
https://doi.org/10.1182/blood.V118.21.856.856
Published: 2011